Tandem positive action of SGLT2 inhibitors and ARNI in patients with heart failure

被引：6
|
作者：
Napoli, Claudio [1 ,2 ]
Gabrielli, Domenico [3 ,4 ]
Gronda, Edoardo [5 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Univ Dept Adv Med & Surg Sci DAMSS, Azienda Osped Univ, I-80138 Naples, Italy
[2] Univ Campania Luigi Vanvitelli, Clin Dept Internal Med & Specialist Units, Azienda Osped Univ, I-80138 Naples, Italy
[3] Azienda Osped San Camillo Forlanini, Div Cardiol, Rome, Italy
[4] Assoc Nazl Med Cardiol Osped ANMCO, Florence, Italy
[5] Fdn IRCCS Ca Granda Osped Maggiore, Policlin Milano UOC Nefrol Dialisi & Trapianto Re, Dipartimento Med & Specialita Med, Milan, Italy
来源：
ACTA DIABETOLOGICA | 2021年 / 58卷 / 11期
关键词：
D O I：
10.1007/s00592-021-01757-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1579 / 1580
页数：2
相关论文
共 50 条
  • [41] SGLT2 inhibitors in heart failure with reduced ejection fraction
    Das, Uday Sankar
    Paul, Aritra
    Banerjee, Suvro
    EGYPTIAN HEART JOURNAL, 2021, 73 (01):
  • [42] The Sweet Spot: Heart Failure Prevention with SGLT2 Inhibitors
    Vardeny, Orly
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (02): : 182 - 185
  • [43] Could SGLT2 inhibitors be heart savers in patients at high risk of developing heart failure?
    Rotkvic, P. Grubic
    Planinic, Z.
    Berkovic, M. Cigrovski
    Bulj, N.
    Sikic, J.
    Galic, E.
    Rotkvic, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 118 - 119
  • [44] Effect of ARNI (Sacubitril/Valsar tan) and SGLT2 Inhibitors (Dapagliflozin) either alone or in Combination on Heart Failure: An Exploration of Novelty
    Ste, Girish B.
    Johns, Joel M.
    Meghana, C. S.
    Srinivasan, R.
    JOURNAL OF YOUNG PHARMACISTS, 2024, 16 (03) : 439 - 446
  • [45] SGLT2 Inhibitors and Their Mode of Action in Heart Failure-Has the Mystery Been Unravelled?
    Pabel, Steffen
    Hamdani, Nazha
    Luedde, Mark
    Sossalla, Samuel
    CURRENT HEART FAILURE REPORTS, 2021, 18 (05) : 315 - 328
  • [46] SGLT2 inhibitors for heart and kidney
    van der Giet, Markus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (22) : 1456 - 1461
  • [47] Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease
    Cheng, Judy W. M.
    Colucci, Vincent
    Kalus, James S.
    Spinler, Sarah A.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (02) : 252 - 260
  • [48] Efficacy of Continuing SGLT2 Inhibitors on Outcomes in Patients with Acute Decompensated Heart Failure
    Nakagaito, Masaki
    Imamura, Teruhiko
    Joho, Shuji
    Ushijima, Ryuichi
    Nakamura, Makiko
    Kinugawa, Koichiro
    INTERNATIONAL HEART JOURNAL, 2021, 62 (04) : 885 - 890
  • [49] Six lessons learned from the use of SGLT2 inhibitors in patients with heart failure
    Packer, Milton
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (08) : 499 - 500
  • [50] SGLT2 inhibitors in patients with amyloidosis and heart failure: a worldwide retrospective cohort study
    Belo Nunes, R.
    Costa, L. M. A.
    Neves, P. M. M.
    Sato, V. A. H.
    Cantarelli, M. J. C.
    Avezum, A.
    EUROPEAN HEART JOURNAL, 2024, 45
12345